Literature DB >> 23430762

Prevention of sexually transmitted infections among girls and young women in relation to their HPV vaccination status.

Delphine Lutringer-Magnin1, Julie Kalecinski, Claire Cropet, Giovanna Barone, Vincent Ronin, Véronique Régnier, Yann Leocmach, Anne-Carole Jacquard, Philippe Vanhems, Franck Chauvin, Christine Lasset.   

Abstract

BACKGROUND: Having been vaccinated against the human papilloma virus (HPV) may affect other behaviours related to sexual health. This study assessed knowledge and behaviour relevant to the prevention of sexually transmitted infections (STIs) among girls/women aged 14-23 years in relation to their HPV vaccination status.
METHODS: From November 2008 to February 2009, 328 girls/women from the Rhône-Alpes region were recruited by general practitioners and completed a self-administered questionnaire.
RESULTS: In all, 316 of the 328 respondents provided information on their HPV vaccination status: 135 (42.7%) had been vaccinated (51.2% of girls aged 14-16 years, 44% of women aged 17-20 years and 18.9% of 21-23-year-olds). Knowledge about HPV and the Pap smear was poor overall but greater in those who had been vaccinated: vaccinated 14-16-year-olds were significantly more likely to know the aim of the Pap smear than those not vaccinated (72.7% vs. 41.3%, P < 0.001), and vaccinated 21-23-year-olds were more likely to know about the need to continue Pap smear screening, despite vaccination (60.0% vs. 25.6%, P = 0.06). Irrespective of vaccination status, >80% cited condoms as a means of STI prevention and >85% of those who were sexually active used them. No difference was observed between vaccinated and non-vaccinated groups regarding requests for HIV serology, history of abortions or emergency hormonal contraception.
CONCLUSION: Knowledge about cervical cancer prevention was better among those who had been vaccinated against HPV than among those who had not. Knowledge and behaviour relevant to STI prevention seemed appropriate whatever the respondents' vaccination status.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23430762     DOI: 10.1093/eurpub/ckt018

Source DB:  PubMed          Journal:  Eur J Public Health        ISSN: 1101-1262            Impact factor:   3.367


  7 in total

1.  The Prevalence of High-Risk Human Papillomavirus in Hungary-A Geographically Representative, Cross-Sectional Study.

Authors:  András István Fogarasi; Márta Benczik; Ágota Moravcsik-Kornyicki; Adrienn Kocsis; Anikó Gyulai; Zsigmond Kósa
Journal:  Pathol Oncol Res       Date:  2022-06-15       Impact factor: 2.874

2.  What Factors Are Associated with Attitudes towards HPV Vaccination among Kazakhstani Women? Exploratory Analysis of Cross-Sectional Survey Data.

Authors:  Gulzhanat Aimagambetova; Aisha Babi; Torgyn Issa; Alpamys Issanov
Journal:  Vaccines (Basel)       Date:  2022-05-23

3.  HPV vaccination coverage among women aged 18-20 years in Germany three years after recommendation of HPV vaccination for adolescent girls: results from a cross-sectional survey.

Authors:  Yvonne Deleré; Merle M Böhmer; Dietmar Walter; Ole Wichmann
Journal:  Hum Vaccin Immunother       Date:  2013-05-31       Impact factor: 3.452

4.  Parental attitudes towards male human papillomavirus vaccination: a pan-European cross-sectional survey.

Authors:  Gitte Lee Mortensen; Marjorie Adam; Laïla Idtaleb
Journal:  BMC Public Health       Date:  2015-07-08       Impact factor: 3.295

Review 5.  Tempest in a teapot: A systematic review of HPV vaccination and risk compensation research.

Authors:  Monica L Kasting; Gilla K Shapiro; Zeev Rosberger; Jessica A Kahn; Gregory D Zimet
Journal:  Hum Vaccin Immunother       Date:  2016-02-10       Impact factor: 3.452

6.  Changes in (risk) behavior and HPV knowledge among Dutch girls eligible for HPV vaccination: an observational cohort study.

Authors:  Robine Donken; Adriana Tami; Mirjam J Knol; Karin Lubbers; Marianne A B van der Sande; Hans W Nijman; Toos Daemen; Willibrord C M Weijmar Schultz; Hester E de Melker
Journal:  BMC Public Health       Date:  2018-07-05       Impact factor: 3.295

7.  Healthcare providers' beliefs and attitudes regarding risk compensation following HPV vaccination.

Authors:  Monica L Kasting; Shannon Wilson; Brian E Dixon; Stephen M Downs; Amit Kulkarni; Gregory D Zimet
Journal:  Papillomavirus Res       Date:  2016-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.